{
    "root": "620f749d-59d2-46fb-befa-7a1356bff383",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Lorbrena",
    "value": "20250501",
    "ingredients": [
        {
            "name": "LORLATINIB",
            "code": "OSP71S83EU",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_143117"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14158"
        },
        {
            "name": "ANHYDROUS DIBASIC CALCIUM PHOSPHATE",
            "code": "L11K75P92J",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_77635"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "HYPROMELLOSE, UNSPECIFIED",
            "code": "3NXW29V3WO",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11075"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17716"
        },
        {
            "name": "TRIACETIN",
            "code": "XHX3C3X673",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_9661"
        },
        {
            "name": "POLYETHYLENE GLYCOL, UNSPECIFIED",
            "code": "3WJQ0SDW1A",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50821"
        },
        {
            "name": "FERRIC OXIDE RED",
            "code": "1K09F3G675",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50819"
        }
    ],
    "indications": {
        "text": "lorbrena\u00ae indicated treatment adult patients metastatic non-small cell lung cancer ( nsclc ) whose tumors anaplastic lymphoma kinase ( alk ) -positive detected fda-approved test .",
        "doid_entities": [
            {
                "text": "non-small cell lung cancer (DOID:3908)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_3908"
            },
            {
                "text": "lung cancer (DOID:1324)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1324"
            },
            {
                "text": "cancer (DOID:162)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_162"
            },
            {
                "text": "lymphoma (DOID:0060058)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_0060058"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "recommended : 100 mg orally daily . ( 2.2 ) severe renal impairment : 75 mg orally daily . ( 2.8 , 8.7 , 12.3 )",
        "doid_entities": [],
        "orphanet_entities": [
            {
                "disease": "severe renal impairment",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_447788"
            }
        ]
    },
    "warningsAndPrecautions": "table 11 describes available strengths package configurations lorbrena : table 11 lorbrena tablets package configuration strength ( mg ) ndc description 30 count bottle child-resistant closure 25 0069-0227-01 8 mm round , tan , immediate release film-coated , debossed `` pfizer `` one side `` 25 `` `` lln `` side 120 count bottle child-resistant closure 25 0069-0227-03 8 mm round , tan , immediate release film-coated , debossed \u201c pfizer \u201d one side \u201c 25 \u201d \u201c lln \u201d side 30 count bottle child-resistant closure 100 0069-0231-01 8.5 mm \u00d7 17 mm oval , lavender , immediate release , film-coated , debossed `` pfizer `` one side `` lln 100 `` side",
    "adverseReactions": "lorbrena contraindicated patients taking strong cyp3a inducers , due potential serious hepatotoxicity [ ( 5.1 ) ] .",
    "indications_original": "LORBRENA\u00ae is indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive as detected by an FDA-approved test.",
    "contraindications_original": "Recommended dosage: 100 mg orally once daily. ( 2.2 ) Severe Renal Impairment: 75 mg orally once daily. ( 2.8 , 8.7 , 12.3 )",
    "warningsAndPrecautions_original": "Table 11 describes the available strengths and package configurations for LORBRENA:\n                  \n                     Table 11 \tLORBRENA Tablets\n                     \n                     \n                     \n                     \n                     \n                        \n                           \n                              Package Configuration\n                           \n                           \n                              Strength\n                              \n                               (mg)\n                           \n                           \n                              NDC\n                           \n                           \n                              Description\n                           \n                        \n                     \n                     \n                        \n                           \n                              30 count bottle with a child-resistant closure\n                           \n                           \n                              25\n                           \n                           \n                              0069-0227-01\n                           \n                           \n                              8 mm round, tan, immediate release film-coated, debossed with \"Pfizer\" on one side and \"25\" and \"LLN\" on the other side\n                           \n                        \n                        \n                           \n                              120 count bottle with a child-resistant closure\n                           \n                           \n                              25\n                           \n                           \n                              0069-0227-03\n                           \n                           \n                              8 mm round, tan, immediate release film-coated, debossed with \u201cPfizer\u201d on one side and \u201c25\u201d and \u201cLLN\u201d on the other side\n                           \n                        \n                        \n                           \n                              30 count bottle with a child-resistant closure\n                           \n                           \n                              100\n                           \n                           \n                              0069-0231-01\n                           \n                           \n                              8.5 mm \u00d7 17 mm oval, lavender, immediate release, film-coated, debossed with \"Pfizer\" on one side and \"LLN 100\" on the other side",
    "adverseReactions_original": "LORBRENA is contraindicated in patients taking strong CYP3A inducers, due to the potential for serious hepatotoxicity [see Warnings and Precautions (5.1)].",
    "drug": [
        {
            "name": "Lorbrena",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_143117"
        }
    ]
}